The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.

Clinical trials to develop a lung cancer vaccine to treat or prevent the most deadly form of cancer in the U.S. could be ...

NPR reports on the National Institutes of Health funding cuts with insight from two NIH staffers and one person familiar with NIH's activities who requested anonymity because they were not authorized ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Pfizer appoints former J&J executive to lead obesity drug development Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

seed funding round. The financing was led by Cambridge Innovation Capital (CIC) and SV Health Investors’ Dementia Discovery Fund (DDF), with M Ventures and Pfizer Ventures joining. Additional ...